Uterine fibroid therapy: the pharmacokinetic considerations

Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):887-889. doi: 10.1080/17425255.2018.1506766. Epub 2018 Aug 2.
No abstract available

Keywords: Leiomyoma; SPRMs; liver injury; oral GnRH antagonist; pharmacokinetics; uterine fibroids.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / pharmacokinetics
  • Drug Development
  • Female
  • Humans
  • Leiomyoma / drug therapy*
  • Leiomyoma / pathology
  • Pharmacokinetics*
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / pathology

Substances

  • Antineoplastic Agents, Hormonal